Assessment of airway inflammation with exhaled NO measurement

Hippokratia

Volumn 11, Issue 2, 2007, Pages 51-62

  Hatziagorou, E ^a,b   Tsanakas, J ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

Airway inflammation; Asthma; Cystic fibrosis; Exhaled nitric oxide; Non invasive monitoring; Primary ciliary dyskinesia

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; CARBON MONOXIDE; CORTICOSTEROID; EOSINOPHIL PEROXIDASE; HYDROCARBON; INDUCIBLE NITRIC OXIDE SYNTHASE; LEUKOTRIENE; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NITRIC OXIDE; PRANLUKAST; PROSTAGLANDIN F2; STEROID;

AGE DISTRIBUTION; ASTHMA; BREATH ANALYSIS; CILIARY DYSKINESIA; CILIARY MOTILITY; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ELECTRON MICROSCOPY; EXPIRED AIR; GRAM NEGATIVE INFECTION; HAY FEVER; HUMAN; NON INVASIVE MEASUREMENT; PATHOPHYSIOLOGY; RESPIRATORY TRACT INFLAMMATION; REVIEW;

EID: 34249947425     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (142)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244
2. Rytila P, Metso T, Heikkinen K, Saarelainen P, Helenius IJ, Haahtela T. Airway inflammation in patients with symptoms suggestive of asthma but with normal lung function. Eur Respir J 2000; 16: 824-830
3. Toorn LM, Prins J, Overbeek SE, et al. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001; 164: 2107-2113
4. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715-1721
5. Vignola AM, Rennar SI, Hargreave FE, et al. Standardised methodology of sputum induction and processing. Future directions. Eur Respir J 2002; 20: Suppl. 37, 51s-55s
6. Kips JC, Kharitonov SA, Barnes PJ. Noninvasive assessment of airway inflammation in asthma. Eur Respir Mon, 2003, 23, 164-179
7. Kips JC, Pauwels RA. Serum eosinophil cationic protein in asthma: what does it mean? Clin Exp Allergy 1998; 28: 1-3
8. Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma. Clin Exp Allergy 1998; 28: 233-240
9. Hoshino M, Nakamura Y. Relationship between activated eosinophils of the bronchial mucosa and serum eosinophil cationic protein in atopic asthma. Int Arch Allergy Immunol 1997; 112: 59-64
10. Ferguson AC, Vaughan R, Brown H, Curtis C. Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma. J Allergy Clin Immunol 1995; 95: 23-28
11. Fujisawa T, Terada A, Atsuta J, Iguchi K, Kamiya H, Sakurai M. Clinical utility of serum levels of eosinophil cationic protein (ECP) for monitoring and predicting clinical course in childhood asthma. Clin Exp Allergy 1998; 28: 19-25
12. Kristjansson S, Strannegard IL, Strannegard O, Peterson C, Enander I, Wennergren G. Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment. J Allergy Clin Immunol 1996; 97: 1179-1187
13. van Velzen E, van den Bos JW, Benckhuijsen JA, van Essel T, de Bruijn R, Aalbers R. Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax 1996; 51: 582-584
14. Zimmerman B, Lanner A, Enander I, Zimmerman RS, Peterson CG, Ahlstedt S. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 1993; 23: 564-570
15. Kumlin M, Stensvad F, Larsson L, Dahlen B, Dahlen SE. Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans. Clin Exp Allergy 1995; 25: 467-479
16. Dahlen SE, Kumlin M. Can asthma be studied in the urine? Clin Exp Allergy 1998; 28: 129-133
17. Kharitonov SA, Barnes PJ. Clinical aspects of exhaled nitric oxide. Eur Respir J 2000; 16:781-792
18. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1693-1722
19. Horvath I. Airway inflammation: exhaled NO measurement in clinical practice. Breathe Vol 1 (3). Pp229-235. 2005
20. Hanazawa T, Kharitonov SA, Barnes PJ. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 2000; 162: 1273-1276
21. Dohlman AW, Black HR, Royall JA. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am Rev Respir Dis 1993; 148: 955-960
22. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999; 160: 216-220
23. Pizzichini E, Pizzichini MM, Efthimiadis A, Dolovich J, Hargreave FE. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol 1997; 99: 539-544
24. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000; 161: 9-16
25. Parameswaran K, Anvari M, Efthimiadis A, Kamada D, Hargreave FE, Allen CJ. Lipid-laden macrophages in induced sputum are a marker of oropharyngeal reflux and possible gastric aspiration. Eur Respir J 2000; 16: 1119-1122
26. Leigh R, Sharon RF, Efthimiadis A, Hargreave FE, Kitching AD. Diagnosis of left-ventricular dysfunction from induced sputum examination (letter). Lancet 1999; 354: 833-834
27. Brightling CE, Pavord ID. Eosinophilic bronchitis - what is it and why is it important? (editorial; comment). Clin Exp Allergy 2000; 30: 4-6
28. Gauvreau GM, Doctor J, Watson RM, JordanaM, O'Byrne PM. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1996; 154: 1267-1271
29. Kips JC, O'Connor BJ, Inman MD, Svensson K, Pauwels RA, O'Byrne PM. A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. Am J Respir Crit Care Med 2000; 161: 996-1001
30. Aizawa H, Iwanaga T, Inoue H, Takata S, Matsumoto K, Takahashi N. Once-daily theophylline reduces serum eosinophil cationic protein and eosinophil levels in induced sputum of asthmatics. Int Arch Allergy Immunol 2000; 121: 123-128
31. Tohda Y, Muraki M, Iwanaga T, Kubo H, Fukuoka M, Nakajima S. The effect of theophylline on blood and sputum eosinophils and ECP in patients with bronchial asthma. Int J Immunopharmacol 1998; 20: 173-181
32. Pizzichini E, Leff JA, Reiss TF, Hendeles L, Boulet LP, Wei LX. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J 1999; 14: 12-18
33. Gershman NH, Wong HH, Liu JT, Fahy JV. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment. Eur Respir J 2000; 15: 11-18
34. Fahy JV, Boushey HA. Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation. Eur Respir J 1998; 11: 1240-1247
35. Veen JC, Smits HH, Hiemstra PS, Zwinderman AE, Sterk PJ, Bel EH. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double blind steroid withdrawal. Am J Respir Crit Care Med 1999; 160: 93-99
36. Paredi P, Kharitonov SA, Barnes PJ. Elevation of exhaled ethane concentration in asthma. Am J Respir Crit Care Med 2000; 162: 1450-1454
37. Uasuf CG, Jatakanon A, James A, Kharitonov SA, Wilson NM, Barnes PJ. Exhaled carbon monoxide in childhood asthma. J Pediatr 1999; 135: 569-574
38. Horvath I, Donnelly LE, Kiss A, Paredi P, Kharitonov SA, Barnes PJ. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax 1998; 53: 668-672
39. Zayasu K, Sekizawa K, Okinaga S, Yamaya M, Ohrui T, Sasaki H. Increased carbon monoxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1997; 156: 1140-1143
40. Olopade CO, Christon JA, Zakkar M, Hua C, Swedler WI, Scheff PA. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 1997; 111: 1500-1504
41. National Heart, Lung and Blood Institute. Global strategy for asthma management and prevention. NHLBI Workshop Report. National Heart, Lung and Blood Institute, 1995. NIH Publication No. 95: 3659
42. Nathan C, Xie Q-W. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-13728
43. Shaul PW, North AJ, Wu LC, et al. Endothelial nitric oxide synthase is expressed in cultured bronchiolar epithelium. J Clin Invest 1994; 94: 2231-2236
44. Asano K, Chee CBE, Gaston B, et al. Constitutive and inducible nitric oxide synthase gene expression, regulation and activity in human lung epithelial cells. Proc Natl Acad Sci USA 1994; 91: 10089-10093
45. Guo FH, de Raeve HR, Rice TW, Stuehr DJ, Thunnissen FBJM, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA 1995; 92: 7809-7813
46. Kobzik L, Bredt DS, Lowenstein CJ, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993; 9: 371-377
47. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993; 342: 1510-1513
48. Robbins RA, Barnes PJ, Springall DR, et al. Expression of inducible nitric oxide synthase in human bronchial epithelial cells. Biochem Biophys Res Commun 1994; 203: 209-218
49. Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 1998; 12: 929-937
50. Kharitonov SA, Yates DH, Barnes PJ. Regular inhaled budesonide decreases nitric oxide concentration in the exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153: 454-457
51. Lundberg JON, Weitzberg E, Nordvall SL, Kuylenstierna R, Lundberg JM, Alving K. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur Respir J 1994; 8: 1501-1504
52. Kharitonov S, Chung KF, Evans DJ, O'Connor BJ, Barnes PJ. Increased exhaled nitric oxide in asthma is derived from the lower respiratory tract. Am J Respir Crit Care Med 1996; 153: 1773-1780
53. Massaro AF, Mehta S, Lilly CM, Kobzik L, Reilly JJ, Drazen JM. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med 1996; 153: 1510-1514
54. American Thoracic Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930.
55. Baraldi E, de Jongste JC. Measurement of exhaled nitric oxide in children, 2001. Eur Respir J 2002; 20: 223-237.
56. Buchvald F, Baraldi E, Carraro S, et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol 2005; 115: 1130-1136
57. Kharitonov SA. Exhaled markers of inflammatory lung diseases: ready for routine monitoring? Swiss Med WKLY 2004; 134:175-192
58. Baraldi E and Carraro S. Exhaled NO and breath condensate. Paediatric Respiratory Reviews 2006 7S, S20-S22
59. Buchvald F, Bisgaard H. FeNO measured at fixed exhalation flow rate during controlled tidal breathing in children from the age of 2 yr. Am J Respir Crit Care Med 2001; 163: 699-704
60. Hall G, Reinmann B, Wildhaber J, Frey U. Tidal exhaled nitric oxide in healthy, unsedated newborn infants with prenatal tobacco exposure. J Appl Physiol 2002; 92: 59-66
61. Wildhaber JH, Hall GL, Stick SM. Measurements of exhaled nitric oxide with the single-breath technique and positive expiratory pressure in infants. Am J Respir Crit Care Med 1999; 159: 74-78
62. Hatziagorou E, Sarafidou S, Kirvassilis F, Emboriadou M, Aivazis V, Tsanakas J. Measurements of exhaled nitric oxide in healthy subjects age 5 to 14 years. Eur Respir J 2006; 28: 259S
63. Kharitonov SA, Barnes PJ. Exhaled Markers of Pulmonary Disease. Am J Respir Crit Care Med 2001; 163:1693-1722
64. ten Hasken NHT, van der Vaart H, van der Mark TW, Kolter GH, Postma DS. Exhaled nitric oxide is higher both at day and night in subjects with nocturnal asthma. Am J Respir Crit Care Med 1998; 158:902-907
65. Purokivi M, Randell J, Hirvonen MR, Tukiainen H. Reproducibility of measurements of exhaled NO, and cell count and cytokine concentrations in induced sputum. Eur Respir J 2000;16:242-246
66. Bartley J, Fergusson W, Moody A, Wells AU, Kolbe J. Normal adult values, diurnal variation, and repeatability of nasal nitric oxide measurement. Am J Rhinol 1999; 13:401-405
67. Deykin A, Massaro AF, Coulston E, Drazen JM, Israel E. Exhaled NO following repeated spirometry or repeated plethysmography in healthy individuals. Am J Respir Crit Care Med 2000; 161:1237-1240
68. Silkoff PE, Wakita S, Chatkin J, et al. Exhaled nitric oxide after beta2-agonist inhalation and spirometry in asthma. Am J Respir Crit Care Med 1999;159:940-944
69. Phillips CR, Giraud GD, Holden WE. Exhaled nitric oxide during exercise: site of release and modulation by ventilation and blood flow. J Appl Physiol 1996;80:1865-1871
70. Piacentini GL, Bodini A, Costella S, Vicentini L, Suzuki Y, Boner AL. Exhaled nitric oxide is reduced after sputum induction in asthmatic children. Pediatr Pulmonol 2000; 29:430-433
71. Nightingale JA, Rogers DF, Barnes PJ. Effect of inhaled ozone on exhaled nitric oxide, pulmonary function, and induced sputum in normal and asthmatic subjects. Thorax 1999; 54:1061-1069
72. Olin AC, Ljungkvist G, Bake B, Hagberg S, Henriksson L, Toren K. Exhaled nitric oxide among pulpmill workers reporting gassing incidents involving ozone and chlorine dioxide. Eur Respir J 1999; 14:828-831
73. van Amsterdam JG, Verlaan BP, van Loveren H, Elzakker BG, Vos SG, Opperhuizen A, Steerenberg PA. Air pollution is associated with increased level of exhaled nitric oxide in nonsmoking healthy subjects. Arch Environ Health 1999;54:331-335
74. Kharitonov SA, Robbins RA, Yates DH, Keatings V, Barnes PJ. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 1995; 152:609-612
75. Robbins RA, Floreani AA, Von Essen SG, et al. Measurement of exhaled nitric oxide by three different techniques. Am J Respir Crit Care Med 1996; 153:1631-1635
76. Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ. The effect of alcohol ingestion on exhaled nitric oxide. Eur Respir J 1996; 9:1130-1133
77. Persson MG, Gustafsson LE. Ethanol can inhibit nitric oxide production. Eur Respir J 1992; 224:99-100
78. Kharitonov SA, Yates DH, Barnes PJ. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory infections. Eur Respir J 1995; 295-297
79. Murphy AW, Platt-Mills TA, Lobo M, Hayden F. Respiratory nitric oxide levels in experimental human influenza. Chest 1999; 114:452-456
80. Ferguson EA, Eccles R. Changes in nasal nitric oxide concentration associated with symptoms of common cold and treatment with a topical nasal decongestant. Acta Otolaryngol 1997; 117:614-617
81. Frank TL, Adisesh A, Pickering AC, et al. Relationship between exhaled nitric oxide and childhood asthma. Am J Respir Crit Care Med 1998; 158:1032-1036
82. Kharitonov SA, O'Connor BJ, Evans DJ, Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 1995; 151:1894-1899
83. Paredi P, Leckie MJ, Horvath I, Allegra L, Kharitonov SA, Barnes PJ. Exhaled carbon monoxide is elevated following allergen challenge in patients with asthma. Eur Respir J 1999; 13:48-52
84. Baraldi E, Carra S, Dario C, et al. Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children. Am J Respir Crit Care Med 1999; 159:262-266
85. Piacentini GL, Bodini A, Costella S, et al. Exhaled nitric oxide in asthmatic children exposed to relevant allergens: effect of flunisolide. Eur Respir J 2000; 15:730-734
86. Simpson A, Custovic A, Pipis S, Adisesh A, Faragher B, Woodcock A. Exhaled nitric oxide, sensitization, and exposure to allergens in patients with asthma who are not taking inhaled steroids. Am J Respir Crit Care Med 1999; 160:45-49
87. Salome CM, Roberts AM, Brown NJ, Dermand J, Marks GB, Woolcock AJ. Exhaled nitric oxide measurements in a population sample of young adults. Am J Respir Crit Care Med 1999; 159:911-916
88. Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 1998; 12:929-937
89. Kharitonov SA, Yates DH, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343:133-135
90. Kharitonov SA, Chung FK, Evans DJ, O'Connor BJ, Barnes PJ. The elevated level of exhaled nitric oxide in asthmatic patients is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 1996; 153:1773-1780
91. Persson MG, Zetterstrom O, Agrenius V, Ihre E, Gustafsson LE. Single- breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994; 343:146-147
92. Chatkin JM, Ansarin K, Silkoff PE, et al. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am J Respir Crit Care Med 1999; 159:1810-1813
93. Dupont LJ, Demedts MG, Verleden GM. Prospective evaluation of the accuracy of exhaled nitric oxide for the diagnosis of asthma [abstract]. Am J Respir Crit Care Med 1999; 159:A861
94. Ludviksdottir D, Janson C, Hogman M, Hedenstrom H, Bjornsson E, Boman G. Exhaled nitric oxide and its relationship to airway responsiveness and atopy in asthma: BHR-Study Group. Respir Med 1999; 93:552-556
95. Ho LP, Wood FT, Robson A, Innes JA, Greening AP. Atopy influences exhaled nitric oxide levels in adult asthmatics. Chest 2000; 118: 1327-1331
96. Silvestri M, Spallarossa D, Yourukova VF, Battistini E, Fregonese B, Rossi GA. Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermitten asthma. Eur Respir J 1999; 13:321-326
97. Moody A, Fergusson W, Wells A, Bartley J, Kolbe J. Increased nitric oxide production in the respiratory tract in asymptomatic Pacific Islanders: an association with skin prick reactivity to house dust mite. J Allergy Clin Immunol 2000;105:895-899
98. Sovijarvi ARA, Saarinen A, Helin T, et al. Increased nitric oxide in exhaled air in patients with asthmatic symptoms not fulfilling the functional criteria of asthma. Eur Respir J 1998; 12:431S
99. Withers NJ, Bale KL, Laszlo G. Levels of exhaled nitric oxide as a screening tool for undiagnosed asthma: results of a pilot study. Eur Respir J 1998; 12:393S
100. Persson MG, Zetterstrom O, Argenius V, Ihre E, Gustaffson LE. Single breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994; 343: 146-147
101. Horvath I, Loukides S, Wodehouse T, et al. Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax 2003; 58: 68-72
102. Gratziou C, Lignos M, Dassiou M, Roussos C. The influence of atopy on exhaled nitric oxide in patients with asthma and/or rhinitis. Eur Respir J 1999; 14: 897-901
103. Nogami H, Shoji S, Nishima S. Exhaled nitric oxide as a simple assessment of airway hyperresponsiveness in bronchial asthma and chronic cough patients. J Asthma 2003; 40: 653-659
104. Dupont LJ, Rochette F, Demedts MG, Verleden GM. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 1998; 157:894-8
105. Parameswaran K, Kamada D, Borm A, et al. Sputum cell counts and exhaled nitric oxide in patients with non-asthmatic cough and gastro-esophageal reflux. Eur Respir J 1998; 12:248S
106. Jatakanon A, Kharitonov SA, Lim S, Barnes PJ. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 1999; 54:108-114
107. Gibson PG, Henry RL, Thomas P. Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J 2000; 16:1008-1015
108. Mattes J, vonStorm G, Reining U, et al. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma. Eur Respir J 1999; 13:1391-1395
109. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53:91-95
110. Dupont LJ, Rochette F, Demedts MG, Verleden GM. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-na?ve patients with mild asthma. Am J Respir Crit Care Med 1998; 157: 894-898
111. Pizzichini E, Pizzichini MM, Kidney JC, et al. Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: inflammatory cells, lymphocyte subsets and soluble markers compared. Eur Respir J 1998; 11:828-834
112. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153:454-457
113. Kharitonov SA, Yates DH, Chung KF, Barnes PJ. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996; 9:196-201
114. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000; 161:64-72
115. Kharitonov SA, Barnes PJ, O'Connor BJ. Reduction in exhaled nitric oxide after a single dose of nebulized budesonide in patients with asthma [abstract]. Am J Respir Crit Care Med 1996; 153:A799
116. Lim S, Jatakanon A, John M, Gilbey T, O'Connor BJ, Barnes PJ. Effect of inhaled budesonide on lung function and airway inflammation. Am J Respir Crit Care Med 1999; 159:22-30
117. Kobayashi H, Takahashi Y, Mitsufuji H, et al. Decreased exhaled nitric oxide in mild persistent asthma patients treated with a leukotriene receptor antagonist, pranlukast. Jpn J Physiol 1999; 49:541-544
118. Bisgaard H, Loland L, Oj JA. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am J Respir Crit Care Med 1999; 160:1227-1231
119. Wilson AM, Orr LC, Sims EJ, Dempsey OJ, Lipworth BJ. Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma. Am J Respir Crit Care Med 2000;162: 1297-1301
120. Stirling RG, Kharitonov SA, Campbell D, et al. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled and corticosteroids. Thorax 1998; 53: 1030-1034
121. Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001; 164: 738-743
122. Artlich A, Busch T, Lewandowski K, Jonas S, Gortner L, Falke KJ. Childhood asthma: exhaled nitric oxide in relation to clinical symptoms. Eur Respir J 1999; 13:1396-1401
123. Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, Drazen JM. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995; 152:800-803
124. Baraldi E, Dario C, Ongaro R, et al. Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children. Am J Respir Crit Care Med 1999; 159:1284-1288
125. Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996; 75:319-322
126. Jones KL, Bryan TW, Jinkins PA, et al. Superoxide causes a reduction in nitric oxide gas and an increase in nitrate. Am J Physiol 1998; 275: L1120-L1126
127. Yu H, Nasr SZ, Deretic V. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis. Infect Immun 2000; 68:2142- 2147
128. Grasemann H, Michler E, Wallot M, Ratjen F. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 1997; 24:173-177
129. Thomas SR, Kharitonov SA, Scott SF, Hodson ME, Barnes PJ. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest 2000; 117:1085-1089
130. Antuni JD, Kharitonov SA, Hughes D, Hodson ME, Barnes PJ. Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis. Thorax 2000; 55:138-142
131. Downey D, Elborn JS. Nitric oxide, iNOS, and inflammation in cystic fibrosis. J Pathol 2000; 190:115-116
132. Kelley TJ, Drumm ML. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 1998; 102:1200-1207
133. Meng QH, Polak JM, Edgar AJ, et al. Neutrophils enhance expression of inducible nitric oxide synthase in human normal but not cystic fibrosis bronchial epithelial cells. J Pathol 2000; 190:126-132
134. Loukides S, Kharitonov SA, Wodehouse T, Cole PJ, Barnes PJ. Effect of L-arginine on mucociliary function in primary ciliary dyskinesia. Lancet 1998; 352:371-372
135. Karadag B, James AJ, Gultekin E, Wilson NM, Bush A. Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia. Eur Respir J 1999; 13:1402-1405
136. Bush A. Primary ciliary dyskinesia. Acta Otorhinolaryngol Belg 2000; 54:317-324
137. Csoma Z, Bush A, Wilson NM, et al. Nitric oxide metabolites are not reduced in exhaled breath condensate of patients with primary ciliary dyskinesia. Chest 2003; 124:633-638
138. Malmberg LP, Pelkonen AS, Haahtela T, Turpeinen M. Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax 2003; 58: 494-499
139. Avital A, Uwyyed K, Berkman N, Godfrey S, Bar-Yishay E, Springer C. Exhaled nitric oxide and asthma in young children. Pediatr Pulmonol 2001; 32: 308-313
140. Zeiger R, Szefler S, Phillips B, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 2006; 117: 45-52
141. Pijnenburg M, Hofhuis W, Hop W, De Jongste J. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005; 60: 215-218
142. Zacharasiewicz A, Wilson N, Lex C, et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005; 171: 1077-1082